Wird geladen...
Review of Venetoclax in CLL, AML and Multiple Myeloma
Venetoclax is a highly selective and effective B-cell lymphoma-2 (BCL-2) inhibitor, which is able to reinstate the apoptotic potential of cancer cells. With its full repertoire yet to be explored, it has changed the therapeutic landscape in haematological malignancies, and most particularly chronic...
Gespeichert in:
| Veröffentlicht in: | J Pers Med |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8225137/ https://ncbi.nlm.nih.gov/pubmed/34073976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060463 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|